Alzheimer's “Prevention” vs. “Risk Reduction”: Transcending Semantics for Clinical Practice
The terms “prevention” and “risk reduction” are often used interchangeably in medicine. There is considerable debate, however, over the use of these terms in describing interventions that aim to preserve cognitive health and/or delay disease progression of Alzheimer's disease (AD) for patients...
Autores principales: | , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6348710/ https://www.ncbi.nlm.nih.gov/pubmed/30719021 http://dx.doi.org/10.3389/fneur.2018.01179 |
_version_ | 1783390151429324800 |
---|---|
author | Hodes, John F. Oakley, Carlee I. O'Keefe, James H. Lu, Peilin Galvin, James E. Saif, Nabeel Bellara, Sonia Rahman, Aneela Kaufman, Yakir Hristov, Hollie Rajji, Tarek K. Fosnacht Morgan, Anne Marie Patel, Smita Merrill, David A. Kaiser, Scott Meléndez-Cabrero, Josefina Melendez, Juan A. Krikorian, Robert Isaacson, Richard S. |
author_facet | Hodes, John F. Oakley, Carlee I. O'Keefe, James H. Lu, Peilin Galvin, James E. Saif, Nabeel Bellara, Sonia Rahman, Aneela Kaufman, Yakir Hristov, Hollie Rajji, Tarek K. Fosnacht Morgan, Anne Marie Patel, Smita Merrill, David A. Kaiser, Scott Meléndez-Cabrero, Josefina Melendez, Juan A. Krikorian, Robert Isaacson, Richard S. |
author_sort | Hodes, John F. |
collection | PubMed |
description | The terms “prevention” and “risk reduction” are often used interchangeably in medicine. There is considerable debate, however, over the use of these terms in describing interventions that aim to preserve cognitive health and/or delay disease progression of Alzheimer's disease (AD) for patients seeking clinical care. Furthermore, it is important to distinguish between Alzheimer's disease prevention and Alzheimer's dementia prevention when using these terms. While prior studies have codified research-based criteria for the progressive stages of AD, there are no clear clinical consensus criteria to guide the use of these terms for physicians in practice. A clear understanding of the implications of each term will help guide clinical practice and clinical research. The authors explore the semantics and appropriate use of the terms “prevention” and “risk reduction” as they relate to AD in clinical practice. |
format | Online Article Text |
id | pubmed-6348710 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-63487102019-02-04 Alzheimer's “Prevention” vs. “Risk Reduction”: Transcending Semantics for Clinical Practice Hodes, John F. Oakley, Carlee I. O'Keefe, James H. Lu, Peilin Galvin, James E. Saif, Nabeel Bellara, Sonia Rahman, Aneela Kaufman, Yakir Hristov, Hollie Rajji, Tarek K. Fosnacht Morgan, Anne Marie Patel, Smita Merrill, David A. Kaiser, Scott Meléndez-Cabrero, Josefina Melendez, Juan A. Krikorian, Robert Isaacson, Richard S. Front Neurol Neurology The terms “prevention” and “risk reduction” are often used interchangeably in medicine. There is considerable debate, however, over the use of these terms in describing interventions that aim to preserve cognitive health and/or delay disease progression of Alzheimer's disease (AD) for patients seeking clinical care. Furthermore, it is important to distinguish between Alzheimer's disease prevention and Alzheimer's dementia prevention when using these terms. While prior studies have codified research-based criteria for the progressive stages of AD, there are no clear clinical consensus criteria to guide the use of these terms for physicians in practice. A clear understanding of the implications of each term will help guide clinical practice and clinical research. The authors explore the semantics and appropriate use of the terms “prevention” and “risk reduction” as they relate to AD in clinical practice. Frontiers Media S.A. 2019-01-21 /pmc/articles/PMC6348710/ /pubmed/30719021 http://dx.doi.org/10.3389/fneur.2018.01179 Text en Copyright © 2019 Hodes, Oakley, O'Keefe, Lu, Galvin, Saif, Bellara, Rahman, Kaufman, Hristov, Rajji, Fosnacht Morgan, Patel, Merrill, Kaiser, Meléndez-Cabrero, Melendez, Krikorian and Isaacson. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Neurology Hodes, John F. Oakley, Carlee I. O'Keefe, James H. Lu, Peilin Galvin, James E. Saif, Nabeel Bellara, Sonia Rahman, Aneela Kaufman, Yakir Hristov, Hollie Rajji, Tarek K. Fosnacht Morgan, Anne Marie Patel, Smita Merrill, David A. Kaiser, Scott Meléndez-Cabrero, Josefina Melendez, Juan A. Krikorian, Robert Isaacson, Richard S. Alzheimer's “Prevention” vs. “Risk Reduction”: Transcending Semantics for Clinical Practice |
title | Alzheimer's “Prevention” vs. “Risk Reduction”: Transcending Semantics for Clinical Practice |
title_full | Alzheimer's “Prevention” vs. “Risk Reduction”: Transcending Semantics for Clinical Practice |
title_fullStr | Alzheimer's “Prevention” vs. “Risk Reduction”: Transcending Semantics for Clinical Practice |
title_full_unstemmed | Alzheimer's “Prevention” vs. “Risk Reduction”: Transcending Semantics for Clinical Practice |
title_short | Alzheimer's “Prevention” vs. “Risk Reduction”: Transcending Semantics for Clinical Practice |
title_sort | alzheimer's “prevention” vs. “risk reduction”: transcending semantics for clinical practice |
topic | Neurology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6348710/ https://www.ncbi.nlm.nih.gov/pubmed/30719021 http://dx.doi.org/10.3389/fneur.2018.01179 |
work_keys_str_mv | AT hodesjohnf alzheimerspreventionvsriskreductiontranscendingsemanticsforclinicalpractice AT oakleycarleei alzheimerspreventionvsriskreductiontranscendingsemanticsforclinicalpractice AT okeefejamesh alzheimerspreventionvsriskreductiontranscendingsemanticsforclinicalpractice AT lupeilin alzheimerspreventionvsriskreductiontranscendingsemanticsforclinicalpractice AT galvinjamese alzheimerspreventionvsriskreductiontranscendingsemanticsforclinicalpractice AT saifnabeel alzheimerspreventionvsriskreductiontranscendingsemanticsforclinicalpractice AT bellarasonia alzheimerspreventionvsriskreductiontranscendingsemanticsforclinicalpractice AT rahmananeela alzheimerspreventionvsriskreductiontranscendingsemanticsforclinicalpractice AT kaufmanyakir alzheimerspreventionvsriskreductiontranscendingsemanticsforclinicalpractice AT hristovhollie alzheimerspreventionvsriskreductiontranscendingsemanticsforclinicalpractice AT rajjitarekk alzheimerspreventionvsriskreductiontranscendingsemanticsforclinicalpractice AT fosnachtmorganannemarie alzheimerspreventionvsriskreductiontranscendingsemanticsforclinicalpractice AT patelsmita alzheimerspreventionvsriskreductiontranscendingsemanticsforclinicalpractice AT merrilldavida alzheimerspreventionvsriskreductiontranscendingsemanticsforclinicalpractice AT kaiserscott alzheimerspreventionvsriskreductiontranscendingsemanticsforclinicalpractice AT melendezcabrerojosefina alzheimerspreventionvsriskreductiontranscendingsemanticsforclinicalpractice AT melendezjuana alzheimerspreventionvsriskreductiontranscendingsemanticsforclinicalpractice AT krikorianrobert alzheimerspreventionvsriskreductiontranscendingsemanticsforclinicalpractice AT isaacsonrichards alzheimerspreventionvsriskreductiontranscendingsemanticsforclinicalpractice |